Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Borsi

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Proteinuria due to suboptimal hydration with high-dose methotrexate therapyG T Kovács, C Paál, P Somló, et al.
Anti-Cancer Drugs|October 1, 1994
Pharmacokinetic studies on Elobromol in children with brain tumorsC Paál, V Erdélyi-Tóth, E Pap, et al.
Pediatric Hematology and Oncology|November 1, 1994
Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemiaD Schuler, B Szende, J D Borsi, et al.
Pediatric Hematology and Oncology|January 1, 1997
Safety of dexrazoxane in children with all undergoing anthracycline therapy: preliminary results of a prospective pilot studyD Schuler, E Horváth, R Koós, et al.
Annals of the New York Academy of Sciences|February 12, 1998
Pediatric oncology outreach to Hungary: a registry of childhood malignanciesE Apjok, J D Borsi, R Koós, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Conduct of phase I trials in children with cancerM Smith, M Bernstein, W A Bleyer, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Proteinuria due to suboptimal hydration with high-dose methotrexate therapyG T Kovács, C Paál, P Somló, et al.
Anti-Cancer Drugs|October 1, 1994
Pharmacokinetic studies on Elobromol in children with brain tumorsC Paál, V Erdélyi-Tóth, E Pap, et al.
Pediatric Hematology and Oncology|November 1, 1994
Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemiaD Schuler, B Szende, J D Borsi, et al.
Pediatric Hematology and Oncology|January 1, 1997
Safety of dexrazoxane in children with all undergoing anthracycline therapy: preliminary results of a prospective pilot studyD Schuler, E Horváth, R Koós, et al.
Annals of the New York Academy of Sciences|February 12, 1998
Pediatric oncology outreach to Hungary: a registry of childhood malignanciesE Apjok, J D Borsi, R Koós, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Conduct of phase I trials in children with cancerM Smith, M Bernstein, W A Bleyer, et al.
Pageof 3